The Foundation supports research that can lead to the creation of better Parkinson's treatments. Here you can search previously awarded grants by keyword, program name, researcher name, institution or organization name and/or year.
FUNDED GRANTS ( 6)
Research Grant, 2017
From Nose to Diagnostics: Development of an Accessible Screening Platform for Early Diagnosis of Parkinson's Disease
The aim of this study is to determine if chemicals found on the skin of those with Parkinson's disease (PD) can be used as a way to diagnose PD before motor symptoms develop. We have preliminary evidence that the sebum (oil from the skin) of those with PD differs from that of those without PD and that odors from the sebum can be used to provide an early diagnostic indicator of the ...
Researchers: Perdita Barran, BSc, Hons PhD
Research Grant, 2013
Ubiquitous, Inexpensive Non-invasive Technologies for Objective Detection and Monitoring of Parkinson's Symptoms
For doctors to diagnose and treat Parkinson's, they need reliable tests. Unfortunately, testing the symptoms of Parkinson's at a specialist's office/clinic is expensive and time-consuming. We have found that voice recordings collected in the clinic contain enough information to detect Parkinson's, but we want to test the same capability over the phone, or using smartphones, suc...
Researchers: Max A. Little, PhD
Rapid Response Innovation Awards, 2013
Several biological processes are thought to cause Parkinson's disease. One involves inflammation within the central nervous system, but so far, no treatments are available for this aspect of the disease. Exciting results from laboratory experiments suggest a class of medicines called glitazones, which are already used to treat diabetes, may reduce or prevent the in...
Researchers: Ian James Douglas, PhD
LRRK2 Biology LEAPS, 2012
Combining Mass Spectrometry with Genetic and Pharmacological Approaches to Discover and Validate LRRK2 Substrates
Much recent work has suggested that comprehending the biological properties of an enzyme termed LRRK2 that is mutated in about one percent of all Parkinson's disease patients, will be crucial for better understanding of the molecular causes of Parkinson's disease as well as designing new strategies to better treat this condition. Our objective is to deploy the state of the a...
Research Grant, 2011
Some people with Parkinson's may develop dementia during their disease course. Being able to detect problems with mental function at an early stage, to monitor and to reliably detect treatment benefits relies critically upon the use of scales. As things stand, there are several scales that record cognitive impairments, but researchers do not know which is best, since they hav...